Actively Recruiting
Efficacy of Triple-daily 15mA tACS on Adolescent NSSI
Led by Shanghai Mental Health Center · Updated on 2025-06-12
66
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In order to assess the clinical efficacy of triple-daily 15mA-tACS stimulation by comparing the effects of active and sham tACS interventions on driving improvements in adolescent Nonsuicidal Self-Injury(NSSI), participants will be randomly assigned to either the active or sham tACS group. This trial consists of a 2-week intensified intervention phase (40 sessions), followed by a 4-week observation period. The key hypothesis is that triple-daily 15mA-tACS stimulation will enhance clinical recovery compared to sham stimulation.
CONDITIONS
Official Title
Efficacy of Triple-daily 15mA tACS on Adolescent NSSI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of NSSI based on DSM-5 criteria section 3
- Five or more NSSI episodes in the past year and at least one episode in the past month
- Age between 12 and 21 years
- Informed consent from parents or legal guardians
- Informed consent from participants aged 15 years and above
You will not qualify if you...
- Current or history of organic brain or neurological disorders
- Elevated or imminent suicidal risk
- Previous or current exposure to ECT, modified ECT, TMS, tDCS, tACS, or other neurostimulation treatments
- Presence of cochlear implants, cardiac pacemakers, implanted devices, or metal in the brain
- Previous or current use of psychotropic medication
- Pregnancy or lactation
- Participation in another clinical trial
- Refusal to provide informed consent
- Other conditions deemed unsuitable by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China, 200030
Actively Recruiting
Research Team
T
TianHong Zhang, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here